Nanobac Pharmaceuticals, Incorporated discovers and develops products and services to improve human health through the detection and treatment of calcifying nanoparticles (CNPs). It manufactures and markets in vitro diagnostic (IVD) kits, such as assays, antibodies, and reagents for detecting CNPs. The company's diagnostic assays comprise NANO-CAPTURE and NANO-SERO. Additionally, it conducts research and clinical studies in the development of urological diseases, including chronic prostatitis/chronic pelvic pain syndrome, kidney stones, and polycystic kidney diseases, as well as cardiovascular diseases. Nanobac Pharmaceuticals, Incorporated was formerly known as HealthCentrics Inc. and changed its name to Nanobac Pharmaceuticals, Incorporated in December 2002. The company was founded in 1994 and is based in Tampa, Florida.
Часто задаваемые вопросы
В каком секторе работает Nanobac Pharmaceuticals Incorporated (NNBP)?
Nanobac Pharmaceuticals Incorporated относится к сектору Здравоохранение.
Какова текущая цена акций Nanobac Pharmaceuticals Incorporated (NNBP)?
По последним данным, цена акций Nanobac Pharmaceuticals Incorporated составляет 0,00 $, предыдущее закрытие — 0,00 $.
Выплачивает ли Nanobac Pharmaceuticals Incorporated (NNBP) дивиденды?
Нет, Nanobac Pharmaceuticals Incorporated не выплачивает дивиденды.
Какой бета-коэффициент (волатильность) у Nanobac Pharmaceuticals Incorporated (NNBP)?
У компании Nanobac Pharmaceuticals Incorporated бета -50.124, что указывает на более низкую волатильность по сравнению с рынком в целом.
